About Synaptogenix, Inc. 
Synaptogenix, Inc.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 3 Schemes (2.56%)
Foreign Institutions
Held by 11 Foreign Institutions (1.6%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
No Data
Revenue and Profits:
Net Sales:
0 Million
(Quarterly Results - Mar 2026)
Net Profit:
4 Million
Pharmaceuticals & Biotechnology
USD 39 Million (Micro Cap)
NA (Loss Making)
NA
0.00%
-1.01
-40.86%
2.33






